C

Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Additional Patients and Extended Follow-Up From the Phase 1/2 BRUIN Study

By Chan Cheah 4 Videos
456 views
March 22, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
10:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
04:34
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Feat. P. Jain
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
16:05
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: What Is High Risk MCL and How Should We Treat It

Feat. A. Kumar
06:43
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…

Feat. V. Yazbeck
07:22
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Hypertension in Pts With CLL and Other Heme…

Feat. A. Ferrajoli
05:28
GRACE

3L Treatment for Mantle Cell Lymphoma

Feat. T. Phillips
12:54
The University of Alabama at Birmingham School of Medicine

Tips and Tricks in Treatment of MCL: Choice of Regimens and Dosing C…

Feat. M. Narkhede
44:19
University of Colorado Division of Hematology

Mantle Cell Lymphoma: Challenges & Prospects

Feat. J. Jasem
06:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pirtobrutinib in cBTKi Pre-Treated MCL - …

Feat. N. Shah
04:13
GRACE

The TRIANGLE Study: Ibrutinib Maintenance for MCL

Feat. T. Phillips
08:19
ASH 2022 Conference Coverage

ASH 2022 Results From the Phase 1/2 BRUIN Study: Safety & Tolera…

Feat. N. Shah
03:26
PrecisCa

The BRUIN Study: Pirtobrutinib in Mantle Cell Lymphoma

Feat. M. Kamdar
34:11
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: Management of MCL

Feat. A. Goy
18:18
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Emerging BCL2 Inhibitors

Feat. M. Ann Anderson
03:42
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BELLWAVE-003 - A Phase 2 Dose Escalation,…

Feat. G. Perini